Al Hadhrami Halah, Al Nabhani Nawal, Al Hadhrami Bader, Al Sumri Hana, Al Sumry Sanaa
Family Medicine Residency Training Program, Oman Medical Specialty Board, Muscat, Oman.
Department of General Surgery, Royal Hospital, Muscat, Oman.
Oman Med J. 2025 Jan 31;40(1):e717. doi: 10.5001/omj.2025.52. eCollection 2025 Jan.
Obesity poses a significant challenge worldwide, increasing the risk of various metabolic diseases, including type 2 diabetes mellitus (T2DM), hypertension (HTN), and dyslipidemia. Bariatric surgery, specifically a laparoscopic sleeve gastrectomy (LSG), is effective in inducing weight loss, thereby improving the rate of obesity-related metabolic diseases. This study aimed to assess the short-term effectiveness and metabolic effects of LSG procedures among patients in Oman.
This retrospective cohort study was conducted at the Royal Hospital, Muscat, Oman, and included patients who underwent LSG between 1 January 2017 and 31 December 2018. Demographic, clinical, and anthropometric data were collected from the hospital's computerized records preoperatively and one year postoperatively.
A total of 168 patients were included in the study, of whom most were female (66.1%). Before surgery, the mean age was 36.1 years, and the mean body mass index (BMI) was 50.8 kg/m. In terms of comorbidities, 28.6% had T2DM, 28.6% had HTN, and 20.8% had dyslipidemia. Postoperatively, more than two-thirds of the cohort (n = 132; 78.6%) achieved a target percent excess weight loss (EWL) of > 50%, including 89.5% and 73.0% of male and female patients, respectively ( 0.014). The percent EWL was positively correlated to preoperative BMI ( < 0.001); however, no significant associations were observed with various comorbidities, including HTN, T2DM, dyslipidemia, and obstructive sleep apnea ( > 0.050).
The results of this study indicate that LSG is effective for the short-term achievement of percent EWL among Omani patients with morbid obesity. However, further studies are needed to assess the long-term effectiveness of LSG on percent EWL and its effect on obesity-related metabolic diseases.
肥胖在全球范围内构成重大挑战，增加了包括2型糖尿病（T2DM）、高血压（HTN）和血脂异常在内的各种代谢性疾病的风险。减重手术，特别是腹腔镜袖状胃切除术（LSG），在诱导体重减轻方面有效，从而提高肥胖相关代谢性疾病的发生率。本研究旨在评估阿曼患者中LSG手术的短期有效性和代谢影响。
这项回顾性队列研究在阿曼马斯喀特的皇家医院进行，纳入了2017年1月1日至2018年12月31日期间接受LSG手术的患者。术前和术后一年从医院的计算机记录中收集人口统计学、临床和人体测量数据。
该研究共纳入168例患者，其中大多数为女性（66.1%）。手术前，平均年龄为36.1岁，平均体重指数（BMI）为50.8kg/m²。就合并症而言，28.6%患有T2DM，28.6%患有HTN，20.8%患有血脂异常。术后，超过三分之二的队列（n = 132；78.6%）实现了>50%的目标超重减轻百分比（EWL），男性和女性患者分别为89.5%和73.0%（P = 0.014）。EWL百分比与术前BMI呈正相关（P < 0.001）；然而，未观察到与包括HTN、T2DM、血脂异常和阻塞性睡眠呼吸暂停在内的各种合并症有显著关联（P > 0.050）。
本研究结果表明，LSG对阿曼病态肥胖患者短期实现EWL百分比有效。然而，需要进一步研究来评估LSG对EWL百分比的长期有效性及其对肥胖相关代谢性疾病的影响。
